Investment Q&A

• Editas Medicine Inc. (EDIT $2.31)
  • $2.31 Cap: $229M
  • View EDIT Profile
  • View Questions on EDIT

Q: Hello,
Why Editas stock go up today?
Thanks!

Upvote 1

Read Answer Asked by Nancy on February 20, 2025

• West Pharmaceutical Services Inc. (WST $240.56)
  • $240.56 P/E (TTM): 35.26X Cap: $17.22B
  • View WST Profile
  • View Questions on WST

Q: Hi 5i,

What do you think of WST? It had a big correction.

Thank you

Upvote 1

Read Answer Asked by Francois on February 20, 2025

• Profound Medical Corp. (PRN $7.22)
  • $7.22 Cap: $227M
  • View PRN Profile
  • View Questions on PRN

Q: Is it time to let it go? Thanks

Upvote 1

Read Answer Asked by Charles on February 19, 2025

• iShares Biotechnology ETF (IBB $163.02)
  • $163.02 P/E (TTM): 20.63X Cap: $7.90B
  • View IBB Profile
  • View Questions on IBB
• State Street SPDR S&P Biotech ETF (XBI $120.59)
  • $120.59 P/E (TTM): 17.2X Cap: $7.24B
  • View XBI Profile
  • View Questions on XBI
• Natera Inc. (NTRA $202.05)
  • $202.05 Cap: $28.03B
  • View NTRA Profile
  • View Questions on NTRA
• ARK Genomic Revolution ETF (ARKG $26.33)
  • $26.33 P/E (TTM): 27.48X Cap: $1.29B
  • View ARKG Profile
  • View Questions on ARKG
• Catalyst Pharmaceuticals Inc. (CPRX $22.25)
  • $22.25 P/E (TTM): 13.8X Cap: $2.78B
  • View CPRX Profile
  • View Questions on CPRX

Q: It looks like biotech stocks are on a tear, especially those that may benefit from AI. Do you have any names that you might recommend? I'm considering the Arkg fund but I don't quite trust Cathy Woods after losing money on the Arkk fund in 2021. Thank you,

Jason

Upvote 6

Read Answer Asked by Jason on February 18, 2025

• Hims & Hers Health Inc. Class A (HIMS $23.35)
  • $23.35 P/E (TTM): 49.96X Cap: $5.27B
  • View HIMS Profile
  • View Questions on HIMS

Q: HIMS

Why the strength in Shares. What is RFK Jr stance on these weight losing companies . 50 % of Americans are overweight and this effects their health , Please comment on other LLY and NOVO Thank you RAK

Upvote 1

Read Answer Asked by bob on February 18, 2025

• Abbott Laboratories (ABT $108.06)
  • $108.06 P/E (TTM): 29.76X Cap: $188.95B
  • View ABT Profile
  • View Questions on ABT
• Eli Lilly and Company (LLY $918.01)
  • $918.01 P/E (TTM): 40.54X Cap: $867.39B
  • View LLY Profile
  • View Questions on LLY
• Pfizer Inc. (PFE $27.33)
  • $27.33 P/E (TTM): 20.18X Cap: $155.40B
  • View PFE Profile
  • View Questions on PFE
• Novo Nordisk A/S (NVO $36.72)
  • $36.72 P/E (TTM): 10.8X Cap: $363.68B
  • View NVO Profile
  • View Questions on NVO
• Moderna Inc. (MRNA $51.82)
  • $51.82 Cap: $20.78B
  • View MRNA Profile
  • View Questions on MRNA

Q: Hello,

Given the current price levels of both MRNA and PFE would this be a good time to take position in either one of those? If so which one would you recommend.

Thank you!

Upvote 3

Read Answer Asked by Irek on February 14, 2025

• Vertex Pharmaceuticals Incorporated (VRTX $450.30)
  • $450.30 P/E (TTM): 30.25X Cap: $114.71B
  • View VRTX Profile
  • View Questions on VRTX

Q: May I please get your thoughts on this company? I like their new non-opioid pain killer that was just approved by the FDA for a strong growth prospect. I am curious what you think about the existing business and the fundamentals/financials of the company. Thanks.

Upvote 2

Read Answer Asked by Marco on February 14, 2025

• Medical Facilities Corporation (DR $16.79)
  • $16.79 P/E (TTM): 9.65X Cap: $307M
  • View DR Profile
  • View Questions on DR

Q: DR Medical Facilities Corp.

What's your opinion on their "Dutch Auction?"

Forecast for the future of this stock, is it worth holding or time to sell?

Thank you.

Upvote 3

Read Answer Asked by Ross on February 13, 2025

• Doximity Inc. Class A (DOCS $24.55)
  • $24.55 P/E (TTM): 20.76X Cap: $4.57B
  • View DOCS Profile
  • View Questions on DOCS

Q: Thank you for your prompt answer; I was not sure whether the company consistently advised much lower prospects or whether there was some seasonality to their earnings. My take is that corporate earnings prospects do need to be as accurate as possible and is an appropriate response, and guidance, to shareholders investment.

Upvote 2

Read Answer Asked by Mike on February 12, 2025

• Quipt Home Medical Corp. (QIPT $4.98)
  • $4.98 Cap: $220M
  • View QIPT Profile
  • View Questions on QIPT

Q: Can you comment on earnings and prospects please

Upvote 1

Read Answer Asked by andrew on February 11, 2025

• Doximity Inc. Class A (DOCS $24.55)
  • $24.55 P/E (TTM): 20.76X Cap: $4.57B
  • View DOCS Profile
  • View Questions on DOCS

Q: Earnings are up but outlook is down - possibly because of Kennedy appointment - would appreciate your comment as I do not seem able to access their earnings statement recording.

Upvote 1

Read Answer Asked by Mike on February 10, 2025

• McKesson Corporation (MCK $913.66)
  • $913.66 P/E (TTM): 27.18X Cap: $112.73B
  • View MCK Profile
  • View Questions on MCK

Q: Your thoughts on the most recent results for MCK would be appreciated. Thanks
Ian

Upvote 1

Read Answer Asked by Ian on February 10, 2025

• iShares Global Healthcare ETF (IXJ $92.39)
  • $92.39 P/E (TTM): 26.33X Cap: $3.65B
  • View IXJ Profile
  • View Questions on IXJ
• State Street Health Care Select Sector SPDR ETF (XLV $146.80)
  • $146.80 P/E (TTM): 23.97X Cap: $38.44B
  • View XLV Profile
  • View Questions on XLV
• Vanguard Health Care ETF (VHT $271.77)
  • $271.77 P/E (TTM): 24.74X Cap: $17.40B
  • View VHT Profile
  • View Questions on VHT

Q: Hello, can you please provide your opinion of IXJ and whether you think it is a buy at its current price.

Also, if there is a different US healthcare ETF that you think is better please provide advise why and what you think a good entry price is.

Thanks as always for the advice.
Paula

Upvote 8

Read Answer Asked by Paula on February 07, 2025

• Vertex Pharmaceuticals Incorporated (VRTX $450.30)
  • $450.30 P/E (TTM): 30.25X Cap: $114.71B
  • View VRTX Profile
  • View Questions on VRTX

Q: Hi 5i,

Would you please provide your opinion on Vertex Pharmaceuticals (VRTX) as a 3-5 year investment.

Does their recent announcement related to an FDA approved non-addictive, non-opioid painkiller have promise?

If so, what would be the longer term implications for the company?

Thanks.

Upvote 4

Read Answer Asked by Brian on February 07, 2025

• Medexus Pharmaceuticals Inc. Common Share Purchase Warrants (MDP.WT $0.01)
  • View MDP.WT Profile
  • View Questions on MDP.WT

Q: Would welcome your analysis on this small cap- it has recently received some positive reports. It appears to be cash flow positive and has a new drug approval.

Upvote 1

Read Answer Asked by Scott on February 07, 2025

• Sensus Healthcare Inc. (SRTS $3.87)
  • $3.87 Cap: $63M
  • View SRTS Profile
  • View Questions on SRTS

Q: I know this is a small cap but it took a big haircut today. Were the results that bad or is it a result of being thinly traded? Thanks as always.

Upvote 1

Read Answer Asked by Nigel on February 06, 2025

• Viemed Healthcare Inc. (VMD $9.19)
  • $9.19 P/E (TTM): 29.36X Cap: $359M
  • View VMD Profile
  • View Questions on VMD
• Vitalhub Corp. (VHI $6.71)
  • $6.71 P/E (TTM): 153.33X Cap: $486M
  • View VHI Profile
  • View Questions on VHI
  • View Reports on VHI

Q: Hi 5I
I own VMD and up nicely, but thinking of switching to VHI for better growth. Could I get your thoughts on this move.

Upvote 3

Read Answer Asked by Maurice on February 06, 2025

• Savaria Corporation (SIS $25.35)
  • $25.35 P/E (TTM): 29.86X Cap: $5.81B
  • View SIS Profile
  • View Questions on SIS
  • View Reports on SIS

Q: Does the recent price decline represent a buying opportunity?

Upvote 7

Read Answer Asked by Thomas on February 05, 2025

• AbbVie Inc. (ABBV $207.36)
  • $207.36 P/E (TTM): 93.12X Cap: $368.38B
  • View ABBV Profile
  • View Questions on ABBV
• Eli Lilly and Company (LLY $918.01)
  • $918.01 P/E (TTM): 40.54X Cap: $867.39B
  • View LLY Profile
  • View Questions on LLY
• Merck & Company Inc. (MRK $114.08)
  • $114.08 P/E (TTM): 15.92X Cap: $283.08B
  • View MRK Profile
  • View Questions on MRK

Q: Your thoughts on Merck this morning please,do you see any upside?I hold it in my rif and am still showing a small profit.Buy,hold or sell?

Upvote 1

Read Answer Asked by John on February 05, 2025

• Pfizer Inc. (PFE $27.33)
  • $27.33 P/E (TTM): 20.18X Cap: $155.40B
  • View PFE Profile
  • View Questions on PFE

Q: Can you please give me your input on PFE earnings. They beat the earnings however stock is down,

Thanks for your great service

Upvote 3

Read Answer Asked by Hector on February 04, 2025